415 related articles for article (PubMed ID: 31715586)
21. Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer.
Wang S; Xiong Y; Zhang Q; Su D; Yu C; Cao Y; Pan Y; Lu Q; Zuo Y; Yang L
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33302293
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
[TBL] [Abstract][Full Text] [Related]
23. Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
Shen Y; Guan Y; Hummel JJ; Shyu CR; Mitchem JB
BMC Cancer; 2020 Feb; 20(1):124. PubMed ID: 32059711
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.
Ye Q; Han X; Wu Z
Bioengineered; 2020 Dec; 11(1):1280-1300. PubMed ID: 33164640
[TBL] [Abstract][Full Text] [Related]
25. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
26. MS4A1 as a Potential Independent Prognostic Factor of Breast Cancer Related to Lipid Metabolism and Immune Microenvironment Based on TCGA Database Analysis.
Li S; Fang Y
Med Sci Monit; 2022 Jan; 28():e934597. PubMed ID: 35091527
[TBL] [Abstract][Full Text] [Related]
27. Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer.
Kwon MJ
Arch Pharm Res; 2019 Nov; 42(11):947-961. PubMed ID: 31707598
[TBL] [Abstract][Full Text] [Related]
28. Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
Wen WX; Leong CO
PLoS One; 2019; 14(4):e0215381. PubMed ID: 31022191
[TBL] [Abstract][Full Text] [Related]
29. Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
Mu G; Ji H; He H; Wang H
Breast Cancer; 2021 Mar; 28(2):513-526. PubMed ID: 33245478
[TBL] [Abstract][Full Text] [Related]
30. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
[TBL] [Abstract][Full Text] [Related]
31. Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer.
Wang S; Zhang Q; Yu C; Cao Y; Zuo Y; Yang L
Brief Bioinform; 2021 Mar; 22(2):2020-2031. PubMed ID: 32141494
[TBL] [Abstract][Full Text] [Related]
32. Clonality, Antigen Recognition, and Suppression of CD8
Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM
Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042
[TBL] [Abstract][Full Text] [Related]
33. Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database.
Yang H; Zhao K; Kang H; Wang M; Wu A
Medicine (Baltimore); 2020 Apr; 99(14):e19561. PubMed ID: 32243373
[TBL] [Abstract][Full Text] [Related]
34. Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.
Chen B; Chen W; Jin J; Wang X; Cao Y; He Y
Dis Markers; 2019; 2019():8901649. PubMed ID: 31781309
[TBL] [Abstract][Full Text] [Related]
35. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K
Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743
[TBL] [Abstract][Full Text] [Related]
37. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
38. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
[TBL] [Abstract][Full Text] [Related]
39. Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer.
Wang H; You S; Fang M; Fang Q
Biomed Res Int; 2020; 2020():3909416. PubMed ID: 33274208
[TBL] [Abstract][Full Text] [Related]
40. Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
Karn T; Jiang T; Hatzis C; Sänger N; El-Balat A; Rody A; Holtrich U; Becker S; Bianchini G; Pusztai L
JAMA Oncol; 2017 Dec; 3(12):1707-1711. PubMed ID: 28750120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
